Patent Grant
11918816
The present invention is generally directed to devices, systems and methods for treating atrial fibrillation. More specifically, the present invention is directed to implantable electrical leads for delivering multi-stage, atrial cardioversion therapy to a patient.
Traditional electrical shock therapies for treating an atrial arrhythmia in a patient typically include delivery of a series of mono- or biphasic shocks, each shock, or pulse, often having a similar electrical characteristic. To deliver such traditional therapy, a wide variety of electrical leads may be used. However, for multi-stage electrical shock therapies, each stage having a potentially different electrical characteristic, the use of standard, known leads may be insufficient.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
When applying multi-stage therapies, there exists a clinical need to minimize lead hardware and maximize therapy options. Embodiments of the present invention minimize the total number of leads required, thereby increasing ease and speed of an implant, and may reduce the total number of conductors in leads, thereby increasing reliability. Published U.S. Patent Application No. 2012/0209343 to Efimov et al., describes and depicts a number of multi-stage atrial cardioversion therapies, the contents of which, other than the claims and express teachings, are herein incorporated by reference in their entirety. Further, it will be understood that the details and variations of construction of leads in accordance with the various embodiments of the present invention can be accomplished in any number of manners of lead construction known to a person of skill in the art and/or in accordance with conventional or proposed standards for implantable leads such as the International Standard 1 (IS-1), DF-1, and IS-6 standards, the disclosures and details of such standards being incorporated herein by reference.
Embodiments of the claimed invention include one or more electrical leads as described below and as depicted in
In an embodiment, the claimed invention comprises a lead having an electrode configuration having physiologic spacing that permits maximum physiologic response.
Referring to
In an embodiment, the lead comprises a plurality of pacing electrodes proximal to the MST coil (vs. tip-ring being distal to the coil) both in the left atrial CS to permit bi-atrial or uni-bi-atrial pacing.
In another embodiment, the lead includes a plurality of electrodes in the right atrium (i.e, not in the coronary sinus) and will permit pacing or sensing of electrical activity.
The spacing of the LA (non-descending) coronary sinus electrodes and coils are unique to human physiology to permit the reduction of the number of the total number of leads.
In an embodiment, the lead includes a coil length which is matched to the physiologic need to maximally cover the left atrium without creating a shortened pathway to the right atrial coils. The lead may accommodate a physiologic distance to one or more physiologically positioned coils so as to maximize atrial recruitment.
Referring to
Such embodiments of the claimed invention may include the ability to select electrode coil pairs pre-implant, per implant or ambulatory for the purpose to maximize first, second, third, or even nth stage therapy. Some such therapies may be coil-delivered, not pacing-delivered, Rx.
Referring also to
Defibrillatory efficacy or refractory extension prolongation while minimizing required energy: Stage 1, 2, . . . n therapy may be delivered for arranging disruption (unpinning) and refractory period. Prolongation is phase dependent and, thus, position of energy dependent. As depicted in
Referring also to
Embodiments of the claimed invention may include a series of these combinations of therapies which first disrupt and then extinguish the arrhythmia. For example, the therapy may require delivery of first combination pathway (2) followed by (3) and then (1) to be successful. The arrhythmia becomes unpinned at, for example, RCA2 only to become established around RCA1, whereby sequence (3) then (2), terminate the arrhythmia.
In an embodiment, the system learns which combination works best to establish which arrhythmia. The sequence of therapies which maximizes termination with minimal energy becomes probabilistically the therapy delivered and/or attempted. The system watches to determine which therapies and therapy combination are most effective.
Referring to
Referring also to
For an arrhythmia of longer duration, a more aggressive therapy (Rx1) may be required. As noted above, the therapy may be comprised of any number of stages and/or combinations of therapy stages delivered through any number of combinations of coils/electrodes. Given that shorter duration arrhythmias are more easily terminated, the therapy may start with less aggressive and, presumably, less perceptible therapy.
Referring to
Any number of selectable electrode configurations have been previously disclosed herein. Here the use of passive electrical devices leverage the relative energy delivered between various coils, electrodes given the relative energy levels of Stage 1 and on. The concept is to minimize the number of unique conductors relative to the current pathways.
Referring also to
So, in an embodiment, to deliver S1 therapy, conductor C1 is energized through junction J1. Diode D1 is forward biased and diode D2 is reverse biased, preventing current from flooding to electrode E1. The S1 therapy is channeled to coil 1. If pacing therapy is, for example, delivered to E1 with C1 being the return pathway (V=0), current is preferentially directed back to the device through C1. Diode 1 offset voltage say 0.7 v, is not overcome and little/no current flows to coil 1.
Various embodiments of the claimed invention are further described and depicted in the attached document Attachment A, “Multi-Stage Therapy Leads”, comprising 6 pages. Attachment A is incorporated by reference herein in its entirety.
Various embodiments of systems, devices and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the invention. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, configurations and locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the invention.
Persons of ordinary skill in the relevant arts will recognize that the invention may comprise fewer features than illustrated in any individual embodiment described above. The embodiments described herein are not meant to be an exhaustive presentation of the ways in which the various features of the invention may be combined. Accordingly, the embodiments are not mutually exclusive combinations of features; rather, the invention may comprise a combination of different individual features selected from different individual embodiments, as understood by persons of ordinary skill in the art.
Any incorporation by reference of documents above is limited such that no subject matter is incorporated that is contrary to the explicit disclosure herein. Any incorporation by reference of documents above is further limited such that no claims included in the documents are incorporated by reference herein. Any incorporation by reference of documents above is yet further limited such that any definitions provided in the documents are not incorporated by reference herein unless expressly included herein.
For purposes of interpreting the claims for the present invention, it is expressly intended that the provisions of Section 112, sixth paragraph of 35 U.S.C. are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.
In one example embodiment, an implantable apparatus is provided for treatment of atrial arrhythmia of a patient using an implantable therapy generator. The apparatus includes: a single-pass lead configured for implantation in the patient such that no electrodes are within a right ventricle of a heart of the patient, the lead including: a proximal portion configured to be connectable to the implantable therapy generator; a body portion having at least two electrodes, the lead configured such that when implanted in the patient the at least two electrodes on the body portion are positioned within or adjacent a right atrium of a heart of a patient; and a distal portion having at least two electrodes, the lead configured such that when implanted in the patient the at least two electrodes on the distal portion are positioned within a blood vessel proximate the left atrium, wherein the implantable therapy generator is programmed to deliver a multi-stage therapy by activating various combinations of at least one electrode of the body portion of the lead and at least one electrode of the distal portion of the lead in response to an indication an atrial arrhythmia has occurred, the multi-stage therapy including at least a first stage for unpinning of one or more singularities associated with the atrial arrhythmia, a second stage for anti-repinning of the one or more singularities associated with the atrial arrhythmia, and a third stage for extinguishing of the one or more singularities associated with the atrial arrhythmia.
In another example embodiment, a method includes: providing a single-pass lead configured for implantation in a patient, the lead including: a proximal portion configured to be connectable to the implantable therapy generator; a body portion having at least two electrodes; and a distal portion having at least two electrodes; and providing instructions, the instructions comprising: implanting the single-pass lead in the patient such that the at least two electrodes on the body portion are positioned within or adjacent a right atrium of a heart of a patient, and such that the at least two electrodes on the distal portion are positioned within a blood vessel proximate the left atrium, and further such that no electrodes are within a right ventricle of a heart of the patient; and causing the implantable therapy generator to deliver a multi-stage therapy according to a program, wherein various combinations of at least one electrode of the body portion of the lead and at least one electrode of the distal portion of the lead are activated in response to an indication an atrial arrhythmia has occurred, the multi-stage therapy including at least a first stage for unpinning of one or more singularities associated with the atrial arrhythmia, a second stage for anti-repinning of the one or more singularities associated with the atrial arrhythmia, and a third stage for extinguishing of the one or more singularities associated with the atrial arrhythmia, wherein each of the stages includes a plurality of pulses.
In an additional example embodiment, a method is provided for treating atrial arrhythmias in a patient with a single-pass lead, the lead including a proximal portion configured to be connectable to the implantable therapy generator, a body portion having at least two electrodes, and a distal portion having at least two electrodes. The method includes: implanting the single-pass lead in the patient such that the at least two electrodes on the body portion are positioned within or adjacent a right atrium of a heart of a patient, and such that the at least two electrodes on the distal portion are positioned within a blood vessel proximate the left atrium, and further such that no electrodes are within a right ventricle of a heart of the patient; and causing the implantable therapy generator to deliver a multi-stage therapy according to a program, wherein various combinations of at least one electrode of the body portion of the lead and at least one electrode of the distal portion of the lead are activated in response to an indication an atrial arrhythmia has occurred, the multi-stage therapy including at least a first stage for unpinning of one or more singularities associated with the atrial arrhythmia, a second stage for anti-repinning of the one or more singularities associated with the atrial arrhythmia, and a third stage for extinguishing of the one or more singularities associated with the atrial arrhythmia, wherein each of the stages includes a plurality of pulses.
The present application is a continuation of U.S. patent application Ser. No. 13/947,840, filed Jul. 22, 2013, which claims the benefit of U.S. Provisional Patent Application No. 61/674,145, filed Jul. 20, 2012, titled “Multi-Stage Atrial Cardioversion Therapy Leads,” the disclosure of each of which is hereby incorporated by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3729008 | Berkovits | Apr 1973 | A |
| 3738370 | Charms | Jun 1973 | A |
| 3942536 | Mirowski et al. | Mar 1976 | A |
| 4136703 | Wittkampf | Jan 1979 | A |
| 4312356 | Sowton et al. | Jan 1982 | A |
| 4384585 | Zipes | May 1983 | A |
| 4390021 | Spurrell et al. | Jun 1983 | A |
| 4398536 | Nappholz et al. | Aug 1983 | A |
| 4403614 | Engle et al. | Sep 1983 | A |
| 4408606 | Spurrell et al. | Oct 1983 | A |
| 4488554 | Nappholz et al. | Dec 1984 | A |
| 4727877 | Kallok | Mar 1988 | A |
| 4768512 | Imran | Sep 1988 | A |
| 4799493 | DuFault | Jan 1989 | A |
| 4932407 | Williams | Jun 1990 | A |
| 4996984 | Sweeney | Mar 1991 | A |
| 4998975 | Cohen et al. | Mar 1991 | A |
| 5007436 | Smits | Apr 1991 | A |
| 5014696 | Mehra | May 1991 | A |
| 5099838 | Bardy | Mar 1992 | A |
| 5107834 | Ideker et al. | Apr 1992 | A |
| 5111811 | Smits | May 1992 | A |
| 5144960 | Mehra et al. | Sep 1992 | A |
| 5163427 | Keimel | Nov 1992 | A |
| 5170802 | Mehra | Dec 1992 | A |
| 5174288 | Bardy et al. | Dec 1992 | A |
| 5184616 | Weiss | Feb 1993 | A |
| 5199429 | Kroll et al. | Apr 1993 | A |
| 5235977 | Hirschberg et al. | Aug 1993 | A |
| 5235978 | Hirschberg et al. | Aug 1993 | A |
| 5243978 | Duffin, Jr. | Sep 1993 | A |
| 5243980 | Mehra | Sep 1993 | A |
| 5247929 | Stoop et al. | Sep 1993 | A |
| 5261400 | Bardy | Nov 1993 | A |
| 5265600 | Adams et al. | Nov 1993 | A |
| 5269319 | Schulte et al. | Dec 1993 | A |
| 5275621 | Mehra | Jan 1994 | A |
| 5279291 | Adams et al. | Jan 1994 | A |
| 5282836 | Kreyenhagen et al. | Feb 1994 | A |
| 5292338 | Bardy | Mar 1994 | A |
| 5292339 | Stephens et al. | Mar 1994 | A |
| 5306291 | Kroll et al. | Apr 1994 | A |
| 5314430 | Bardy | May 1994 | A |
| 5324309 | Kallok | Jun 1994 | A |
| 5330509 | Kroll et al. | Jul 1994 | A |
| 5334219 | Kroll | Aug 1994 | A |
| 5344429 | Smits | Sep 1994 | A |
| 5350403 | Stroetmann et al. | Sep 1994 | A |
| 5360435 | DeGroot | Nov 1994 | A |
| 5365391 | Sugiyama et al. | Nov 1994 | A |
| 5366484 | Kroll | Nov 1994 | A |
| 5372605 | Adams et al. | Dec 1994 | A |
| 5374279 | Duffin, Jr. et al. | Dec 1994 | A |
| 5374287 | Rubin | Dec 1994 | A |
| 5376103 | Anderson et al. | Dec 1994 | A |
| 5383907 | Kroll | Jan 1995 | A |
| 5383908 | Sweeney et al. | Jan 1995 | A |
| 5385575 | Adams | Jan 1995 | A |
| 5387613 | Goldberg et al. | Feb 1995 | A |
| 5391185 | Kroll | Feb 1995 | A |
| 5391186 | Kroll et al. | Feb 1995 | A |
| 5403351 | Saksena | Apr 1995 | A |
| 5403356 | Hill et al. | Apr 1995 | A |
| 5405363 | Kroll et al. | Apr 1995 | A |
| 5405374 | Stein | Apr 1995 | A |
| 5407444 | Kroll | Apr 1995 | A |
| 5413591 | Knoll | May 1995 | A |
| 5423865 | Bowald et al. | Jun 1995 | A |
| 5431683 | Bowald et al. | Jul 1995 | A |
| 5433729 | Adams et al. | Jul 1995 | A |
| 5439481 | Adams | Aug 1995 | A |
| 5439484 | Mehra | Aug 1995 | A |
| 5441518 | Adams et al. | Aug 1995 | A |
| 5449377 | Adams et al. | Sep 1995 | A |
| 5476502 | Rubin | Dec 1995 | A |
| 5489293 | Pless et al. | Feb 1996 | A |
| 5514160 | Kroll et al. | May 1996 | A |
| 5522853 | Kroll | Jun 1996 | A |
| 5531764 | Adams et al. | Jul 1996 | A |
| 5534019 | Paspa | Jul 1996 | A |
| 5545181 | Jacobson et al. | Aug 1996 | A |
| 5545182 | Stotts et al. | Aug 1996 | A |
| 5545186 | Olson et al. | Aug 1996 | A |
| 5545189 | Fayram | Aug 1996 | A |
| 5545204 | Cammilli et al. | Aug 1996 | A |
| 5545205 | Schulte et al. | Aug 1996 | A |
| 5549642 | Min et al. | Aug 1996 | A |
| 5562708 | Combs et al. | Oct 1996 | A |
| 5591211 | Meltzer | Jan 1997 | A |
| 5601607 | Adams | Feb 1997 | A |
| 5620464 | Kroll et al. | Apr 1997 | A |
| 5620468 | Mongeon et al. | Apr 1997 | A |
| 5620469 | Kroll | Apr 1997 | A |
| 5620477 | Pless et al. | Apr 1997 | A |
| 5626619 | Jacobson et al. | May 1997 | A |
| 5628778 | Kruse et al. | May 1997 | A |
| 5630834 | Bardy | May 1997 | A |
| 5641326 | Adams | Jun 1997 | A |
| 5658321 | Fayram et al. | Aug 1997 | A |
| 5662689 | Elsberry et al. | Sep 1997 | A |
| 5662692 | Paspa et al. | Sep 1997 | A |
| 5674248 | Kroll et al. | Oct 1997 | A |
| 5676687 | Ayers | Oct 1997 | A |
| 5683429 | Mehra | Nov 1997 | A |
| 5683431 | Wang | Nov 1997 | A |
| 5690686 | Min et al. | Nov 1997 | A |
| 5713924 | Min et al. | Feb 1998 | A |
| 5713926 | Hauser et al. | Feb 1998 | A |
| 5718718 | Kroll et al. | Feb 1998 | A |
| 5722995 | Olson et al. | Mar 1998 | A |
| 5735876 | Kroll et al. | Apr 1998 | A |
| 5735878 | Kroll et al. | Apr 1998 | A |
| 5755736 | Gillberg et al. | May 1998 | A |
| 5755742 | Scheulke et al. | May 1998 | A |
| 5766226 | Pedersen | Jun 1998 | A |
| 5776168 | Gunderson | Jul 1998 | A |
| 5782876 | Flammang | Jul 1998 | A |
| 5792187 | Adams | Aug 1998 | A |
| 5797967 | KenKnight | Aug 1998 | A |
| 5813999 | Ayers et al. | Sep 1998 | A |
| 5814079 | Kieval | Sep 1998 | A |
| 5817131 | Elsberry et al. | Oct 1998 | A |
| 5830236 | Mouchawar et al. | Nov 1998 | A |
| 5836975 | DeGroot | Nov 1998 | A |
| 5840079 | Warman et al. | Nov 1998 | A |
| 5855593 | Olson et al. | Jan 1999 | A |
| 5871510 | Kroll et al. | Feb 1999 | A |
| 5891043 | Ericksen et al. | Apr 1999 | A |
| 5906633 | Mouchawar et al. | May 1999 | A |
| 5913887 | Michel | Jun 1999 | A |
| 5916238 | Hauser et al. | Jun 1999 | A |
| 5916243 | KenKnight et al. | Jun 1999 | A |
| 5925066 | Kroll et al. | Jul 1999 | A |
| 5928270 | Ramsey, III | Jul 1999 | A |
| 5928271 | Hess et al. | Jul 1999 | A |
| 5935160 | Auricchio et al. | Aug 1999 | A |
| 5987356 | DeGroot | Nov 1999 | A |
| 5995871 | Knisley | Nov 1999 | A |
| 5995876 | Kruse et al. | Nov 1999 | A |
| 6006139 | Kruse et al. | Dec 1999 | A |
| 6007493 | Ericksen et al. | Dec 1999 | A |
| 6026332 | Kenknight et al. | Feb 2000 | A |
| 6032079 | KenKnight et al. | Feb 2000 | A |
| 6038483 | KenKnight et al. | Mar 2000 | A |
| 6041256 | Michel | Mar 2000 | A |
| 6058327 | Borgerding et al. | May 2000 | A |
| 6059739 | Baumann | May 2000 | A |
| 6070081 | Takahashi et al. | May 2000 | A |
| 6081745 | Mehra | Jun 2000 | A |
| 6081746 | Pendekanti et al. | Jun 2000 | A |
| 6085116 | Pendekanti et al. | Jul 2000 | A |
| 6085119 | Scheiner et al. | Jul 2000 | A |
| 6091988 | Warman et al. | Jul 2000 | A |
| 6091989 | Swerdlow et al. | Jul 2000 | A |
| 6091991 | Warren | Jul 2000 | A |
| 6094596 | Morgan | Jul 2000 | A |
| 6096064 | Routh | Aug 2000 | A |
| 6134470 | Routh | Aug 2000 | A |
| 6146338 | Gardeski et al. | Nov 2000 | A |
| 6152954 | Scheiner et al. | Nov 2000 | A |
| 6152955 | KenKnight et al. | Nov 2000 | A |
| 6157859 | Alt | Dec 2000 | A |
| 6157860 | Hauser et al. | Dec 2000 | A |
| 6178350 | Olson et al. | Jan 2001 | B1 |
| 6178351 | Mower | Jan 2001 | B1 |
| 6185459 | Mehra et al. | Feb 2001 | B1 |
| 6205357 | Ideker et al. | Mar 2001 | B1 |
| 6212434 | Scheiner et al. | Apr 2001 | B1 |
| 6233483 | Causey, III et al. | May 2001 | B1 |
| 6246906 | Hsu et al. | Jun 2001 | B1 |
| 6249701 | Rajasekhar et al. | Jun 2001 | B1 |
| 6272380 | Warman et al. | Aug 2001 | B1 |
| 6280462 | Hauser et al. | Aug 2001 | B1 |
| 6292691 | Pendekanti et al. | Sep 2001 | B1 |
| 6295475 | Morgan | Sep 2001 | B1 |
| 6321122 | Scheiner et al. | Nov 2001 | B1 |
| 6327500 | Cooper et al. | Dec 2001 | B1 |
| 6330477 | Casavant | Dec 2001 | B1 |
| 6345204 | Scheiner et al. | Feb 2002 | B1 |
| 6411851 | Winkler | Jun 2002 | B1 |
| 6438416 | Michel | Aug 2002 | B1 |
| 6438418 | Swerdlow et al. | Aug 2002 | B1 |
| 6442429 | Hill et al. | Aug 2002 | B1 |
| 6442430 | Ferek-Petric | Aug 2002 | B1 |
| 6445948 | Somdahl et al. | Sep 2002 | B1 |
| 6449506 | Sh. Revishvili et al. | Sep 2002 | B1 |
| 6459932 | Mehra | Oct 2002 | B1 |
| 6463330 | Rabinovitch et al. | Oct 2002 | B1 |
| 6463334 | Flynn et al. | Oct 2002 | B1 |
| 6470211 | Ideker et al. | Oct 2002 | B1 |
| 6470212 | Weijand et al. | Oct 2002 | B1 |
| 6477420 | Struble et al. | Nov 2002 | B1 |
| 6477422 | Splett | Nov 2002 | B1 |
| 6485440 | Gardeski | Nov 2002 | B1 |
| 6487443 | Olson et al. | Nov 2002 | B2 |
| 6501983 | Natarajan et al. | Dec 2002 | B1 |
| 6501994 | Janke et al. | Dec 2002 | B1 |
| 6505082 | Scheiner et al. | Jan 2003 | B1 |
| 6510342 | Park et al. | Jan 2003 | B1 |
| 6514195 | Ferek-Petric | Feb 2003 | B1 |
| 6526311 | Begemann | Feb 2003 | B2 |
| 6526317 | Hsu et al. | Feb 2003 | B2 |
| 6539257 | KenKnight | Mar 2003 | B1 |
| 6546287 | Havel et al. | Apr 2003 | B1 |
| 6549812 | Smits | Apr 2003 | B1 |
| 6556862 | Hsu et al. | Apr 2003 | B2 |
| 6556873 | Smits | Apr 2003 | B1 |
| 6560484 | Kroll et al. | May 2003 | B1 |
| 6567691 | Stadler | May 2003 | B1 |
| 6567698 | Herleikson | May 2003 | B2 |
| 6574505 | Warren | Jun 2003 | B1 |
| 6577896 | Werner et al. | Jun 2003 | B2 |
| 6580946 | Struble | Jun 2003 | B2 |
| 6587720 | Hsu et al. | Jul 2003 | B2 |
| 6595927 | Pitts-Crick et al. | Jul 2003 | B2 |
| 6609028 | Struble | Aug 2003 | B2 |
| 6650938 | Boute | Nov 2003 | B2 |
| 6650941 | Ferek-Petric | Nov 2003 | B2 |
| 6654637 | Rouw et al. | Nov 2003 | B2 |
| 6671549 | Van Dam et al. | Dec 2003 | B2 |
| 6675044 | Chen | Jan 2004 | B2 |
| 6695790 | Van Oort et al. | Feb 2004 | B2 |
| 6711442 | Swerdlow et al. | Mar 2004 | B1 |
| 6718211 | Smits | Apr 2004 | B2 |
| 6721597 | Bardy et al. | Apr 2004 | B1 |
| 6721599 | de Vries | Apr 2004 | B2 |
| 6731978 | Olson et al. | May 2004 | B2 |
| 6731982 | Kroll et al. | May 2004 | B1 |
| 6741893 | Smits | May 2004 | B2 |
| 6741894 | Michel | May 2004 | B2 |
| 6745073 | Kroll | Jun 2004 | B1 |
| 6745076 | Helland et al. | Jun 2004 | B2 |
| 6745081 | Helland et al. | Jun 2004 | B1 |
| 6748270 | Rouw et al. | Jun 2004 | B2 |
| 6754531 | Kroll et al. | Jun 2004 | B1 |
| 6760615 | Ferek-Petric | Jul 2004 | B2 |
| 6763266 | Kroll | Jul 2004 | B1 |
| 6766196 | Kroll et al. | Jul 2004 | B1 |
| 6772007 | Kroll | Aug 2004 | B1 |
| 6792308 | Corbucci | Sep 2004 | B2 |
| 6795731 | Kroll et al. | Sep 2004 | B1 |
| 6813516 | Ujhelyi et al. | Nov 2004 | B2 |
| 6836682 | Van Dam | Dec 2004 | B2 |
| 6847842 | Rodenhiser et al. | Jan 2005 | B1 |
| 6873870 | Ferek-Petric | Mar 2005 | B2 |
| 6882882 | Struble et al. | Apr 2005 | B2 |
| 6889078 | Struble et al. | May 2005 | B2 |
| 6901291 | Stoop et al. | May 2005 | B2 |
| 6907286 | Kroll et al. | Jun 2005 | B1 |
| 6910084 | Augustijn et al. | Jun 2005 | B2 |
| 6915169 | Flynn et al. | Jul 2005 | B2 |
| 6934586 | Struble et al. | Aug 2005 | B2 |
| 6937896 | Kroll | Aug 2005 | B1 |
| 6983185 | Ley et al. | Jan 2006 | B2 |
| 6987999 | Kroll | Jan 2006 | B1 |
| 6996437 | Kramm | Feb 2006 | B2 |
| 6999814 | Hauser et al. | Feb 2006 | B2 |
| 7006867 | Kroll | Feb 2006 | B1 |
| 7020517 | Weiner | Mar 2006 | B2 |
| 7024244 | Muhlenberg et al. | Apr 2006 | B2 |
| 7027861 | Thompson | Apr 2006 | B2 |
| 7027862 | Dahl et al. | Apr 2006 | B2 |
| 7031771 | Brown et al. | Apr 2006 | B2 |
| 7037266 | Ferek-Petric et al. | May 2006 | B2 |
| 7047071 | Wagner et al. | May 2006 | B2 |
| 7058443 | Struble | Jun 2006 | B2 |
| 7058450 | Struble et al. | Jun 2006 | B2 |
| 7076290 | Sheth et al. | Jul 2006 | B2 |
| 7076294 | Bardy et al. | Jul 2006 | B2 |
| 7076298 | Padmanabhan et al. | Jul 2006 | B2 |
| 7079891 | Kroll | Jul 2006 | B1 |
| 7082336 | Ransbury et al. | Jul 2006 | B2 |
| 7096063 | Wanasek et al. | Aug 2006 | B2 |
| 7103409 | Warren | Sep 2006 | B2 |
| 7110811 | Wagner et al. | Sep 2006 | B2 |
| 7113822 | Kroll | Sep 2006 | B1 |
| 7120490 | Chen et al. | Oct 2006 | B2 |
| 7120496 | Bardy et al. | Oct 2006 | B2 |
| 7127292 | Warman et al. | Oct 2006 | B2 |
| 7130687 | Cho et al. | Oct 2006 | B2 |
| 7136702 | Wanasek | Nov 2006 | B2 |
| 7139611 | Kroll et al. | Nov 2006 | B1 |
| 7142927 | Benser et al. | Nov 2006 | B2 |
| 7142928 | Sharma et al. | Nov 2006 | B2 |
| 7146214 | Struble | Dec 2006 | B2 |
| 7149577 | Sharma et al. | Dec 2006 | B2 |
| 7151963 | Havel et al. | Dec 2006 | B2 |
| 7155286 | Kroll et al. | Dec 2006 | B1 |
| 7162300 | van Groeningen et al. | Jan 2007 | B2 |
| 7164948 | Struble et al. | Jan 2007 | B2 |
| 7174208 | DeGroot et al. | Feb 2007 | B2 |
| 7181272 | Struble et al. | Feb 2007 | B2 |
| 7181274 | Rissmann et al. | Feb 2007 | B2 |
| 7181276 | Province et al. | Feb 2007 | B1 |
| 7190245 | Receveur et al. | Mar 2007 | B2 |
| 7191002 | Kroll et al. | Mar 2007 | B1 |
| 7194304 | Bornzin et al. | Mar 2007 | B1 |
| 7200438 | Euler | Apr 2007 | B2 |
| 7203544 | Legay et al. | Apr 2007 | B2 |
| 7203547 | Kroll et al. | Apr 2007 | B1 |
| 7215998 | Wesselink et al. | May 2007 | B2 |
| 7231249 | Mower | Jun 2007 | B2 |
| 7231255 | Kroll et al. | Jun 2007 | B1 |
| 7233822 | Hettrick et al. | Jun 2007 | B2 |
| 7239925 | Bardy et al. | Jul 2007 | B2 |
| 7242978 | Cao et al. | Jul 2007 | B2 |
| 7248921 | Palreddy et al. | Jul 2007 | B2 |
| 7248924 | Casavant et al. | Jul 2007 | B2 |
| 7274962 | Bardy et al. | Sep 2007 | B2 |
| RE39897 | Mower | Oct 2007 | E |
| 7277745 | Natarajan et al. | Oct 2007 | B2 |
| 7299092 | Bardy et al. | Nov 2007 | B2 |
| 7299097 | Bardy et al. | Nov 2007 | B2 |
| 7302300 | Bardy et al. | Nov 2007 | B2 |
| 7313436 | Bardy et al. | Nov 2007 | B2 |
| 7317941 | Stomberg et al. | Jan 2008 | B2 |
| 7330757 | Ostroff et al. | Feb 2008 | B2 |
| 7346392 | KenKnight | Mar 2008 | B2 |
| 7363078 | Vonk et al. | Apr 2008 | B2 |
| 7366574 | Michel | Apr 2008 | B2 |
| 7369892 | Ferek-Petric | May 2008 | B2 |
| 7376458 | Palreddy et al. | May 2008 | B2 |
| 7379772 | Bardy et al. | May 2008 | B2 |
| 7386343 | Kroll et al. | Jun 2008 | B1 |
| 7386344 | Bocek et al. | Jun 2008 | B2 |
| 7386346 | Struble | Jun 2008 | B2 |
| 7388459 | Receveur et al. | Jun 2008 | B2 |
| 7392085 | Warren et al. | Jun 2008 | B2 |
| 7392095 | Flynn et al. | Jun 2008 | B2 |
| 7428437 | Bardy et al. | Sep 2008 | B2 |
| 7444182 | Ostroff et al. | Oct 2008 | B2 |
| 7477935 | Palreddy et al. | Jan 2009 | B2 |
| 7480351 | Hiatt, Jr. et al. | Jan 2009 | B2 |
| 7496408 | Ghanem et al. | Feb 2009 | B2 |
| 7502646 | Sheldon et al. | Mar 2009 | B2 |
| 7502647 | Sheldon et al. | Mar 2009 | B2 |
| 7515958 | Sheldon et al. | Apr 2009 | B2 |
| 7515959 | Hess | Apr 2009 | B2 |
| 7522958 | Ideker et al. | Apr 2009 | B2 |
| 7522959 | Hauser et al. | Apr 2009 | B2 |
| 7529589 | Williams et al. | May 2009 | B2 |
| 7536222 | Bardy et al. | May 2009 | B2 |
| 7542799 | Stoop et al. | Jun 2009 | B2 |
| 7555338 | Ostroff | Jun 2009 | B2 |
| 7565196 | Sheldon et al. | Jul 2009 | B2 |
| 7577480 | Zeijlemaker | Aug 2009 | B2 |
| 7593773 | Boute et al. | Sep 2009 | B2 |
| 7596410 | Kroll et al. | Sep 2009 | B1 |
| 7599740 | Betzold et al. | Oct 2009 | B2 |
| 7617007 | Williams et al. | Nov 2009 | B2 |
| 7623909 | Sanghera et al. | Nov 2009 | B2 |
| 7623913 | Phillips | Nov 2009 | B2 |
| 7623916 | Julian | Nov 2009 | B2 |
| 7623920 | Ostroff | Nov 2009 | B2 |
| 7627367 | Warran et al. | Dec 2009 | B2 |
| 7627375 | Bardy et al. | Dec 2009 | B2 |
| 7634316 | Swerdlow et al. | Dec 2009 | B2 |
| 7643877 | Dujmovic, Jr. et al. | Jan 2010 | B2 |
| 7655014 | Ko et al. | Feb 2010 | B2 |
| 7657311 | Bardy et al. | Feb 2010 | B2 |
| 7986992 | Ideker et al. | Jul 2011 | B2 |
| 8175702 | Efimov et al. | May 2012 | B2 |
| 8473051 | Wessels et al. | Jun 2013 | B1 |
| 8560066 | Efimov et al. | Oct 2013 | B2 |
| 8706216 | Efimov et al. | Apr 2014 | B2 |
| 9814895 | Efimov et al. | Nov 2017 | B2 |
| 10441805 | Efimov et al. | Oct 2019 | B2 |
| 11097120 | Efimov et al. | Aug 2021 | B2 |
| 20020128565 | Rudy | Sep 2002 | A1 |
| 20030083727 | Casavant et al. | May 2003 | A1 |
| 20030125773 | Havel et al. | Jul 2003 | A1 |
| 20030220676 | Helland | Nov 2003 | A1 |
| 20040111123 | Ware et al. | Jun 2004 | A1 |
| 20040220641 | Wagner et al. | Nov 2004 | A1 |
| 20050096701 | Donovan et al. | May 2005 | A1 |
| 20050154420 | Diaz et al. | Jul 2005 | A1 |
| 20060161206 | Efimov et al. | Jul 2006 | A1 |
| 20070021793 | Voegele et al. | Jan 2007 | A1 |
| 20070088395 | Province et al. | Apr 2007 | A1 |
| 20090062877 | Krinski et al. | Mar 2009 | A1 |
| 20090204164 | Efimov et al. | Aug 2009 | A1 |
| 20100016917 | Efimov et al. | Jan 2010 | A1 |
| 20100324616 | Livnat et al. | Dec 2010 | A1 |
| 20110009916 | Efimov et al. | Jan 2011 | A1 |
| 20110029032 | Bardy et al. | Feb 2011 | A1 |
| 20120203297 | Efimov et al. | Aug 2012 | A1 |
| 20120209343 | Efimov et al. | Aug 2012 | A1 |
| 20130006319 | Doerr | Jan 2013 | A1 |
| 20160243372 | Efimov et al. | Aug 2016 | A1 |
| 20180243576 | Efimov et al. | Aug 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 0 393 265 | Oct 1990 | EP |
| 1 062 971 | Dec 2000 | EP |
| 2 025 236 | Jan 1980 | GB |
| WO 1996011035 | Apr 1996 | WO |
| WO 2006042295 | Apr 2006 | WO |
| WO 2008063498 | May 2008 | WO |
| WO 2009108502 | Sep 2009 | WO |
| WO 2011119662 | Sep 2011 | WO |
| WO 2011146498 | Nov 2011 | WO |
| WO 2011163339 | Dec 2011 | WO |
| WO 2012012591 | Jan 2012 | WO |
| WO 2012027252 | Mar 2012 | WO |
| WO 2013102062 | Jul 2013 | WO |
| Entry |
|---|
| Peters et al., “Disturbed Connexin43 Gap Junction Distribution Correlates With the Location of Reentrant Circuits in the Epicardial Border Zone of Healing Canine Infarcts That Cause Ventricular Tachycardia,” Circulation, 1997, 95:988-996, USA. |
| Niemann et al., “Intracardiac Voltage Gradients during Transthoracic Defibrillation: Implications for Postshock Myocardial Injury,” Acad. Emerg. Med., Feb. 2005, 12(2):99-105, USA. |
| Kodama et al., “Aftereffects of high-intensity DC stimulation of the electromechanical performance of ventricular muscle”, Am J. Physiol., 1994, 267:H248-H258, USA. |
| Li et al., “Defibrillation Shocks Produce Different Effects on Purkinje Fibers and Ventricular Muscle: Implications for Successful Defibrillation, Refibrillation and Postshock Arrhythmia”, J Am Coll Cardiol, 1993, 22:607-614, USA. |
| Zhou et al., “Epicardial Mapping of Ventricular Defibrillation With Monophasic and Biphasic Shocks in Dogs,” Circulation Research, Jan. 1993, 72(1):145-160, USA. |
| Li et al., “Mechanisms of enhanced shock-induced arrhythmogenesis in the rabbit heart with healed myocardial infarction,” Am. J. Physiol. Heart Circ Physiol., May 3, 2005, 289:H1054-H1068, USA. |
| Sambelashvili et al., “Nonlinear effects in subthreshold virtual electrode polarization,” Am. J. Physiol. Heart Circ, Physiol., 2003, 284(6):H2368-H2374, USA. |
| Aguel et al., “Advances in Modeling Cardiac Defibrillation,” Int'l Journal of Bifurcation & Chaos, 2003, 13(12):3791-3803, USA. |
| Hillebrenner et al., “Postshock arrhythmogenesis in a slice of the canine heart,” J. Cardiovasc. Electrophys., 2003, 14:S249-S256, USA. |
| Trayanova et al., “Virtual Electrode-Induced Positive and Negative Graded Responses: New Insights into Fibrillation Induction and Defibrillation,” J. Cardiovascular Electrophysiology, 2003, 14(7):756-763, USA. |
| Larson et al., “Analysis of Electrically-Induced Reentrant Circuits in a Sheet of Myocardium,” Annals Biomed. Eng., 2003, 31:768-780, USA. |
| Efimov, “Fibrillation or Neurillation: Back to the future in our concepts of sudden cardiac death?”, Circ. Res., May 30, 2003, 92(10):1062-1064, USA. |
| Efimov et al., “Diastolic Shocking Experience: Do Virtual Anodes Exist Only During Systole?”, J. Cardiovascular Electrophysiology, Nov. 2003, 14(11):1223-1224, USA. |
| Efimov et al., Fast Fluorescent Mapping of Electrical Activity in the Heart: Practical Guide to Experimental Design and Applications, Chapter 7, pp. 131-156, USA, 2003. |
| Cheng et al., “Shock-induced arrhythmogenesis is enhanced by 2,3-butanedione monoxime compared with cytochalasin D,” Am. J. Physiol. Heart Circ. Physiol., 2004, 286:H310-H318, USA. |
| Takagi et al., “Unpinning and Removal of a Rotating Wave in Cardiac Muscle”, Phys. Review Letters, Jul. 30, 2004, 93(5):058101-1-058101-4, USA. |
| Li et al., “Effects of Lidocaine on Shock-Induced Vulnerability”, J. Cardiovascular Electrophysiology, Oct. 2003, 14(10):S237-S248, USA. |
| Cheng et al., “Mechanisms of Shock-Induced Arrhythmogenesis During Acute Global Ischemia”, Am J Physiol. Heart Circ. Physiol., Jun. 2002, 282(6)H2141-51, USA. |
| Qu et al., “Mechanisms of Superiority of Ascending Ramp Waveforms: New Insights into Mechanisms of Shock-induced Vulnerability and Defibrillation,” Am. J. Physiol. Heart Circ. Physiol., 2005, 289:H569-H577, USA. |
| Ashihara et al., “Spiral Wave Control by a Localized Stimulus: A Bidomain Model Study,” J. Cardiovascular Electrophysiology, Feb. 2004 15(2):226-233, USA. |
| Ramanathan, “Noninvasive electrocardiogramaging for cardiac electrophysiology and arrhythmia,” Nature Medicine, Apr. 2004, 10(4):422-428, USA. |
| Nikolski et al., “Fluorescent Imaging of a Dual-Pathway Atrioventricular-Nodal Conduction System,” Circ Res., Feb. 16, 2001, pp. 1-7, USA. |
| Qu et al., “The Gurvich waveform has lower defibrillation threshold than the rectilinear waveform and the truncated exponential waveform in the rabbit heart,” Can. J. Physiol. Pharmacol., 2005, 83:152-160, USA. |
| Grosu et al., “Learning and Detecting Emergent Behavior in Networks of Cardiac Myocytes”, Communications of the ACM, Mar. 2009, pp. 97-104, vol. 52, No. 3, USA. |
| Ripplinger et al., “Mechanisms of unpinning and termination of ventricular tachycardia”, Am J. Physiol. Heart Circ. Physiol., 2006, pp. H184-H192, USA. |
| Sepulveda et al., “Current injection into a two-dimensional anisotropic bidomain”, Biophys. J., vol. 55, May 1989, pp. 987-999, USA. |
| Allessie et al., “Regional Control of Atrial Fibrillation by Rapid Pacing in Conscious Dogs”, Circulation, vol. 84, No. 4, Oct. 1991, pp. 1689-1697, USA. |
| Daoud et al., “Response of Type I Atrial Fibrillation to Atrial Pacing in Humans,” Circulation, vol. 94, No. 5, 1996, 13 pages, USA. |
| Disertori et al., “Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry”, European Heart Journal Supplements, 2001, pp. 16-24, USA. |
| Pumir et al., “Unpinning of a Rotating Wave in Cardiac Muscle by an Electric Field”, J. Theor. Biol., vol. 199, 1999, pp. 311-319, USA. |
| Ladwig et al., “Absence of an Impact of Emotional Distress on the Perception of Intracardiac Shock Discharges,” International Journal of Behavioral Medicine, 2003, 10(1):56-65, USA. |
| Fishler et al., “Spatiotemporal Effects of Syncytial Heterogeneities on Cardiac Far-field Excitations during Monophasic and Biphasic Shocks”, Journal of Cardiovascular Electrophysiolgy, 1998, 9(12):1310-24, USA. |
| Efimov et al., “Virtual Electrode-Induced Phase Singularity: A Basic Mechanism of Defibrillation Failure,” Circulation Research, 1998, 82(8):918-25, USA. |
| Efimov et al., “Transmembrane Voltage Changes Produced by Real and Virtual Electrodes During Monophasic Defibrillation Shock Delivered by an Implantable Electrode,” Journal of Cardiovascular Electrophysiology, 1997, 8(9):1031-45, USA. |
| Cheng et al., “Virtual Electrode-Induced Reexcitation: A Mechanism of Defibrillation,” Circulation Research, 1999, 85(11):1056-66, USA. |
| Fishler, “Syncytial Heterogeneity as a Mechanism Underlying Cardiac Far-Field Stimulation During Defibrillation-Level Shocks,” Journal of Cardiovascular Electrophysiology, 1998, 9(4):384-94, USA. |
| Tsukerman et al., “Defibrillation of the Heart by a Rotating Current Field,” Kardiologiia, 1973, 13(12):75-80, USA. |
| Zheng et al., “Reduction of the Internal Atrial Defibrillation Threshold with Balanced Orthogonal Sequential Shocks,” Journal of Cardiovascular Electrophysiology, 2002; 13(9):904-9, USA. |
| Hucker et al., “Atrioventricular conduction with and without AV nodal delay: two pathways to the bundle of His in the rabbit heart”, Am J. Physiol. Heart Circ. Physiol., 2007, 293:H1122-H1130, USA. |
| Mowrey et al., “Membrane Time Constant During Internal Defibrillation Strength Shocks in Intact Heart: Effects of Na+ and Ca2+ Channel Blockers,” J. Cardiovascular Electrophysiology, Apr. 25, 2004, Jun. 8, 2008 and Jan. 2009, 20(1):85-92, USA. |
| Cartee et al., “The Transient Subthreshold Response of Spherical and Cylindrical Cell Models to Extracellular Stimulation”, IEEE Trans. Biomed. Eng., vol. 39, No. 1, Jan. 1992, pp. 76-85. |
| Ideker et al., “Correlation Among Fibrillation, Defibrillation and Cardiac Pacing”, Pacing Clin. Electrophysiol., vol. 18, Mar. 1995, pp. 512-525. |
| Sobie et al., “A Generalized Activating Function for Predicting Virtual Electrodes in Cardiac Tissue”, Biophys. J., vol. 73, Sep. 1997, pp. 1410-1423. |
| Trayanova et al., “The Response of a Spherical Heart to a Uniform Electric Field: A Bidomain Analysis of Cardiac Stimulation”, J. IEEE trans. Biomed. Eng., vol. 40, No. 9, Sep. 1993, pp. 899-908. |
| Davidenko et al., “Stationary and drifting spiral waves of excitation in isolated cardiac muscle,” Nature, vol. 355, pp. 349-351, Jan. 23, 1992. |
| Gray et al., “Spatial and temporal organization during cardiac fibrillation,” Nature, vol. 392, pp. 75-78, 1998. |
| Witkowski et al, “Spatiotemporal evolution of ventricular fibrillation,” Nature, vol. 392, pp. 78-82, Mar. 5, 1998. |
| Cherry et al, “Visualization of spiral and scroll waves in simulated and experimental cardiac tissue”, New J. Phys., vol. 10, 44 pp., 2008. |
| Koster et al., “A randomized trial comparing monophasic and biphasic waveform shocks for external cardioversion of atrial fibrillation,” Am. Heart. J. vol. 147, pp. 828.e1-828.e7, 2004. |
| Babbs et al., “Therapeutic indices for transchest defibrillator shocks: Effective, damaging, and lethal electrical doses,” Am. Heart J., vol. 99, No. 6, pp. 734-738, Jun. 1980. |
| Santini et al., “Single Shock Endocavitary Low Energy Intracardiac Cardioversion of Chronic Atrial Fibrillation,” J. Interv. Card. Electrophysiol., vol. 3, pp. 45-51, 1999. |
| Sakurai et al., “Design and Control of Wave Propagation Patterns in Excitable Media,” Science, vol. 296, pp. 2009-2012, Jun. 14, 2002. |
| Rappel et al, “Spatiotemporal Control of Wave Instabilities in Cardiac Tissue,” Phys. Rev. Lett., vol. 83, No. 2, pp. 456-459, Jul. 12, 1999. |
| Fenton et al., “Multiple mechanisms of spiral wave breakup in a model of cardiac electrical activity,” Chaos, vol. 12, No. 3, pp. 852-892, Sep. 2002. |
| Fenton et al., “Vortex dynamics in three-dimensional continuous myocardium with fiber rotation: Filament instability and fibrillation,” Chaos, vol. 8, No. 1, pp. 20-47, Mar. 1998. |
| MacKenzie, “Making sense of a heart gone wild,” Science, vol. 303, pp. 786-787, Feb. 6, 2004. |
| Walcott et al., “Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction?” Resuscitation, vol. 59, pp. 59-70, 2003. |
| Plonsey, “The Nature of Sources of Bioelectric and Biomagnetic Fields,” Biophys. J., vol. 39, pp. 309-312, 1982. |
| Fast et al., “Activation of Cardiac Tissue by Extracellular Electrical Shocks: Formation of ‘Secondary Sources’ at Intercellular Clefts in Monolayers of Cultured Myocytes,” Circ. Res., vol. 82, pp. 375-385, 1998. |
| Sambelashvili et al., “Virtual electrode theory explains pacing threshold increase caused by cardiac tissue damage,” Am. J. Physiol. Heart Circ. Physiol., vol. 286, pp. H2183-H2194, 2004. |
| Hooks et al, “Cardiac Microstructure: Implications for Electrical Propagation and Defibrillation in the Heart,” Circ. Res., vol. 91, pp. 331-338, 2002. |
| Trayanova et al., “Modeling Defibrillation: Effects of Fiber Curvature,” J. Electrocardiol., vol. 31 (suppl.), pp. 23-29, 1998. |
| Roth et al., “A Bidomain Model for the Extracellular Potential and Magnetic Field of Cardiac Tissue,” IEEE Trans. Biomed. Eng., vol. 33, No. 4, pp. 467-469, Apr. 1986. |
| Murray, “The Physiological Principle of Minimum Work: I. The Vascular System and the Cost of Blood Volume,” Proc. Natl. Acad. Sci. USA, vol. 12, pp. 207-214, 1926. |
| Kassab, “Scaling laws of vascular trees: of form and function,” Am. J. Physiol. Heart Circ. Physiol., vol. 290, pp. H894-H903, 2006. |
| Maleckar et al., “Polarity reversal lowers activation time during diastolic field stimulation of the rabbit ventricles: insights into mechanisms,” Am. J. Physiol. Heart Circ. Physiol., vol. 295, pp. H1626-H1633, 2008. |
| Kirchhof et al., “Regional entrainment of Atrial Fibrillation Studied by High-Resolution Mapping in Open-Chest Dogs,” Circulation, vol. 88, pp. 736-749, 1993. |
| Pumir et al., “Wave Emission from Heterogeneities Opens a Way to Controlling Chaos in the Heart,” Phys. Rev. Lett., vol. 99, pp. 208101-1-208101-4, 2007. |
| Gray et al, “Termination of spiral waves during cardiac fibrillation via shock-induced phase resetting,” Proc. Natl. Acad. Sci. USA, vol. 102, No. 13, pp. 4672-4677, Mar. 29, 2005. |
| Gressard et al., “Pacing Lead/Myocardium Interface: Modeling and Characterization of the Impedance”, Computers in Cardiology, vol. 32, pp. 901-903, 2005. |
| Klafter, “An Optimally Energized Cardiac Pacemaker,” IEEE Trans Biomed. Eng., 1973, vol. 20, pp. 350-356. |
| Kostov et al., “Comparison Between Two Defibrillation Waveforms,” Journal of Medical Engineering & Technology, Nov. 2010, vol. 34, Nos. 7-8, pp. 429-436. |
| Krasteva et al., “Transthoracic Defibrillation with Chopping-Modulated Biphasic Waveforms,” Journal of Medical Engineering & Technology, vol. 25, No. 4, Jul./Aug. 2001, pp. 163-168. |
| Antropov et al., “An Experimental Defibrillator with Programmable Pulse Shape,” Biomedical Engineering, vol. 41, No. 1, Nov. 2007, pp. 7-11. |
| Sweeney et al., “Defibrillation Using a High-Frequency Series of Monophasic Rectangular Pulses: Observations and Model Predictions,” J. Cardiovasc Electrophysiology, 1996, vol. 7, pp. 134-143. |
| Janardhan et al., “Multi-Stage Electrotherapy Delivered Through Chronically Implanted Leads Terminates Atrial Fibrillation with Lower Energy than a Single Biphasic Shock,” Journal of the American College of Cardiology, 2013, 27 pages. |
| Walcott et al., “Internal Atrial Cardioversion with Ultrashort Pulses,” Heart Rhythm 2012—33rd Annual Scientific Sessions, May 2012, 1 page. |
| Janardhan et al., “A Novel Low-Energy Electrotherapy that Terminates Ventricular Tachycardia with Lower Energy than a Biphasic Shock when Antitachycardia Pacing Fails,” Journal of the American College of Cardiology, 2012, vol. xx, No. x, 6 pages. |
| Wenwen et al., “Low-Energy Multistage Atrial Defibrillation Therapy Terminates Atrial Fibrillation with Less Energy than a Single Shock,” Circ. Arrhythm Electrophysiol, 2011, pp. 917-925. |
| Gerstenfeld et al, “Internal Atrial Defibrillation Revisited—How low can we go?,” Journal of the American College of Cardiology, 2013, 9 pages. |
| Winkle, “Evolution of the Implantable Cardioverter-Defibrillator,” Journal of the American College of Cardiology, 2012, vol. xx, No. x, 3 pages. |
| Luther et al., “Low-Energy Control of Electrical Turbulence in the Heart,” Macmillan Publishers Limited, Jul. 2011, vol. 475, pp. 235-241. |
| Berger et al., “Instead of Defibrillator's Painful Jolt, There May be a Gentler Way to Prevent Suddent Death, According to Hopkins Scientists,” Press Release Johns Hopkins Medicine, 2011, 1 page. |
| Supplementary Partial European Search Report for European Application No. 08858734.0, dated Nov. 17, 2011, 11 pages. |
| European Patent Office, European Office Action for European Application No. 05825356.8, dated Oct. 5, 2009, 6 pages, Munich, Germany. |
| Written Opinion/Search Report for Int'l Application No. PCT/US2008/086483, dated Jun. 25, 2009, 14 pages. |
| Search Report for Int'l Application No. PCT/US2012/072046, dated Apr. 25, 2013, 3 pages. |
| Application and File history for U.S. Appl. No. 13/340,637, filed Dec. 19, 2011, now U.S. Pat. No. 8,473,051. Inventors: Shelton et al. |
| Fenton et al., “Termination of Atrial Fibrillation Using Pulsed Low-Energy Far-Field Stimulation,” Circulation, vol. 120, pp. 467-476, 2009. |
| PCT/US2012/072046, International Search Report, dated Apr. 25, 2013, 3 pages. |
| PCT/US2005/040187, Written Opinion, dated Feb. 24, 2009, 6 pages. |
| PCT/US2007/023836, International Search Report, dated Apr. 9, 2008, 7 pages. |
| PCT/US2008/086483, International Search Report, dated Jun. 25, 2009, 14 pages. |
| PCT/US2011/033547, International Search Report, dated Jan. 17, 2012, 4 pages. |
| PCT/US2008/086483, Written Opinion, dated Jun. 15, 2010, 7 pages. |
| Terry, Medtronic Model 7250 Jewel AF Implantable Cardioverter Defibrillator System, Dec. 5, 2000, 15 pages. |
| Gold et al., Clinical Experience with a Dual-Chamber Implantable Cardioverter Defibrillator to Treat Atrial Tachyarrhythmias, Nov. 2001, 7 pages. |
| Wellens et al., Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation, 1998, 7 pages. |
| Daoud et al., Initial Clinical Experience with Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation, 2000, 8 pages. |
| Cooper et al., Internal Cardioversion of Atrial Fibrillation, 1997, 9 pages. |
| Lok et al., Clinical Shock Tolerability and Effect of Different Right Atrial Electrode Locations on Efficacy of Low Energy Human Transvenous Atrial Defibrillation Using an Implantable Lead System, Nov. 1, 1997, 7 pages. |
| International Search Report and Written Opinion dated Sep. 13, 2023 issued in International Application No. PCT/US2023/024547. |
| Ge et al. “Cardiac Arrhythmia Classification Using Autoregressive Modeling”, BioMedical Engineering Online, Nov. 13, 2002, 12 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20210121703 A1 | Apr 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61674145 | Jul 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13947840 | Jul 2013 | US |
| Child | 17140333 | US |
